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SUCCESS OF MACULAR HOLE SURGERY WITH OR WITHOUT INTERNAL 
LIMITING MEMBRANE PEELING 
ELI LEVITT 
ABSTRACT 
This consecutive nonrandomized comparative interventional study was 
designed to examine the association between pars plana vitrectomy (PPV) with or 
without internal limiting membrane (ILM) peeling in the treatment of idiopathic 
macular holes (IMH). The ILM is the innermost layer of the retina. The macula is 
located within the retina, and is responsible for central vision. Although IMH 
manifests in a relatively small region within the retina, patients notice significant 
drops in visual acuity up to the 20/400 - 20/800 level (legally blind in the affected 
eye).   In the literature, the anatomic success rate of macular hole surgery has 
been reported between 48% - 94%. To best treat idiopathic macular holes, it is 
imperative that physicians have access to the most up-to-date information 
regarding the treatment outcomes. 
This study included 55 eyes of 52 patients who received surgery at the Beth 
Israel Deaconess Medical Center for idiopathic macular holes between December 
1999 and January 2015. Patients were non-randomly assigned to PPV with or 
without ILM peeling. Early patients did not receive ILM peeling, while more recent 
patients did.   
The primary endpoint measured was macular hole (MH) status as 
established by ocular coherence tomography (OCT) within 6 to 12 months of the 
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procedure. 36 out of 39 (92.3%) eyes in the ILM peeling group had closed MH. In 
the comparison group without ILM peeling, 11 out of 16 (68.8%) eyes had closed 
MH. In comparison to the conventional PPV without ILM peeling, these findings 
suggest that PPV with ILM peeling is associated with a significantly higher 
anatomic success rate (OR, 5.45; [95% CI, 1.12 to 26.55]; P = 0.023).  
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INTRODUCTION 
Idiopathic age-related macular hole 
Spontaneous macular holes, sometimes called senile or idiopathic, cause 
loss of central vision. Although idiopathic age-related macular holes were first 
described over one hundred years ago, the disease was considered untreatable 
until the 1990s. Morgan and Schatz (1986) proposed that atrophic changes due to 
ischemia resulted in a process referred to as “involutional macular thinning.” 
Furthermore, they asserted that a posterior vitreous detachment (PVD) contributed 
to the pathogenesis by pulling on the thinned fovea. Alternatively, Donald Gass 
(1988) believed that tangential contraction of the attached prefoveal vitreous cortex 
led to the development of spontaneous macular holes. Gass’s theoretical 
framework for a pathophysiological mechanism causing macular holes represents 
a watershed moment in the history of this rare disease; clarifying the biological 
mechanism was not simply a result of a single investigation but represents the 
necessity of piloting experimental treatments to advance clinical science. 
The appropriate surgical technique to treat idiopathic macular holes is 
subject to ongoing debate. In 1991, Kelly and Wendel published their seminal 
report on a successful intervention for idiopathic macular holes (IMH). With 60% 
success rates, and limited understanding of the biophysiological mechanism they 
were treating, Kelly and Wendel laid the foundation to treat this previously 
incurable condition (Kelly & Wendel, 1991). Their technique has been repeated in 
numerous studies (Guyer, 1990; Olsen, 1998; Ryan E. H., 1994; Thompson, 1996; 
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Tornambe, 1997; Wendel, 1993; Freeman W. R.-H., 1997).  Nevertheless, there is 
a need for further exploration and information that not only demonstrates improved 
success, but is repeatable, and affirms a biologic mechanism for hole formation.   
The macula is located within the retina and is responsible for central vision 
(Figure 1). The retina, which is the photosensitive layer that lines the innermost 
surface of the eye, is part of the central nervous system. To appropriately treat 
idiopathic macular holes, it is imperative that physicians have access to the most 
up-to-date information regarding the treatment options. The purpose of this study 
is to describe which surgical techniques provide the best results. If indeed internal 
limiting membrane peeling is associated with successful surgery, then tangential 
perifoveal traction likely plays a significant role in the development of idiopathic 
macular holes.   
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Source: (Vaughan, 1992) 
 
  
Figure 1. Anatomy of the eye. 
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Anatomical considerations 
A macular hole manifests in the posterior chamber of the eye. The posterior 
chamber contains the vitreous humor and retina. At the center of the retina, an 
area 5.5 mm in diameter is referred to as the macula. The macula is lateral to the 
optic nerve, with a depression at its center (Figure 1, Figure 3).  The fovea is the 
depression in the inner retinal surface in the center of the macula (Figure 2). 
According to Alfaro, “The macula is recognized as the specialized region of the 
retina in charge of high-resolution visual acuity.” (Alfaro, Mieler, Quiroz-Mercado, 
Jager, & Tano, 2006) Alfaro’s description of the macula demonstrates how the 
defining characteristic of this area is based on regional structure and function. 
Structurally, the macula is the area of the retina that contains xanthophyll and two 
or more layers of ganglion cells. The fovea, which is the central part of the macula, 
is located 2.5 disc diameters (DD) temporal to the optic disc.  The anatomical 
distribution of rods, cones and pigments varies throughout the retina, thinning at 
the fovea. The largest concentration of cones, which relay the perception of color 
vision, is found in the macula. Due to the anatomic location, a retinal hole located 
within the macula is directly associated with functional loss of central vision.  
The retina includes ten layers from the innermost internal limiting membrane 
(ILM) to the outermost retinal pigment epithelium (RPE) (Figure 2). The ILM is a 
basement membrane of Müller cells and is composed of mainly type IV collagen 
and glycoprotein. The RPE plays a supportive role, aiding in the continuous 
renewal of the photoreceptors. The photosensitive layer includes neurons such as 
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photoreceptors (rods and cones), bipolar cells, horizontal cells and amacrine cells. 
The neurosensory part of the retina is what detaches in a retinal detachment.  
 The inner segment and outer segment layer of photoreceptors contain the 
functional photoreceptor neurons which convert photons of light into chemical 
energy. The chemical energy is transmitted via action potentials as signals through 
the optic nerve to the optic chiasm to the occipital lobe. The mechanism of 
converting light sensation into perception relies on the rods and cones, which are 
dispersed throughout the retina.  The fovea (Figure 2) has the highest 
concentration of cones, which are essential for color vision. Furthermore, the fovea 
is the only location in the retina where there is a 1:1 relationship between cones 
and ganglion cells. The direct synapse between a cone and ganglion cell 
minimizes the receptive field (the region of stimulus space that can activate it) 
thereby increasing the resolution (the ability to resolve detail in an image).   
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Source: (Alfaro, Mieler, Quiroz-Mercado, Jager, & Tano, 2006) 
 
 
  
  
Figure 3. Diagram of a normal fundus showing 
location of the macula. 
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What is a Macular Hole?  
A macular hole is a rare retinal condition. Although age-related macular 
degeneration affects the same area of the eye, there is no direct connection 
between the two separate diseases. According to the textbook Retina, “A macular 
hole is a full-thickness neurosensory retinal defect usually surrounded by a 
localized annular neurosensory retinal detachment” (Ryan S. J., 2001). The optical 
coherence image (Figure 4) displays the two hallmarks of a macular hole: that the 
defect affects all layers of the retina (full-thickness) and is circular in shape 
(annular). Clinically, the majority of macular holes occur idiopathically, i.e., without 
any known cause. Once a macular hole begins to form, progression to a full-
thickness macular hole happens within weeks to months. Since Gass first 
proposed his theory on tangential vitreous traction contributing to macular holes, 
the success of pars plana vitrectomy, which effectively alleviates vitreous traction, 
has supported the Gass theoretical framework. Factors including myopia 
(nearsightedness), peripheral lattice degeneration, posterior vitreous detachment 
(PVD), retinal tear and retinal detachment are all implicated as risk factors for 
developing a macular hole.  The causes of a macular hole are fundamental 
concepts that need further clarification. 
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Figure 4. Optical coherence tomography fundus photo  
(A) macular hole versus (B) fellow eye with normal macula. (C) Close-up of 
outlined box in image A displaying a full-thickness macular hole with arrows 
pointing to the edges.  
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Clinical Manifestation 
Signs and symptoms of idiopathic macular holes include flashing lights, 
increase in floaters and loss of peripheral vision. The flashing lights are a common 
symptom representing an abnormal relationship between the retina and the 
vitreous. Floaters are a common symptom indicating an abnormal vitreous.  
According to Vaughan’s description:  
The patient is aware of a localized  “light,” “glow,” “streak of light,” or 
“flashing” (as of a neon tube) in the field of vision in the absence of a 
corresponding light source …” “…A given floater represents the patient’s 
awareness of the shadow of a mobile vitreous opacity cast upon the retina.” 
(Vaughan, 1992) Patients may also experience metamorphopsia (distortion 
of visual images) as well as a central scotoma (blind spot). (p. 180-181)  
The formation of a macular hole typically manifests unilaterally (in one eye) as 
seen in the optical coherence tomographic B-scan (Figure 5). The condition occurs 
predominately in women aged 50 to 70.  Approximately 90% of cases are classified 
as idiopathic macular holes. (Oh & Roy, Macular Hole, 2014) The remaining cases 
may be due to trauma or prior ocular disease. Although factors such as vitreoretinal 
traction, posterior vitreous traction and adhesion are considered to play a role in 
the dynamics of the disease, there is no consensus on whether or not conditions 
such as posterior vitreous detachment are protective. The primary focus of this 
project, however, is not etiological.  The research herein aims to contribute to the 
ongoing inquiry into best practices for the treatment of idiopathic macular holes.  
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Figure 5. FTMH on OCT  
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Prevention 
Preventing a spontaneous macular hole is impossible. Considering the 
Gass stages of development, it was suggested that patients with early stage holes 
may benefit from prophylactic therapy before forming a full-thickness macular hole.  
However, Ho et al. (Ho, Guyer, & Fine, 1998) found that treatment of Stage 1 MH 
was no better than observation. The difficulty in identifying Stage 1 MH probably 
underlies these results.   
How do doctor’s treat it?  
Full-thickness macular holes were once considered untreatable, and 
surgery was believed to be indicated only if an extensive retinal detachment 
occurred (Ryan 2552). Patients who are experiencing the development of a 
macular hole typically have a progressive decline in vision up to 20/400 – 20/800 
over a period from six to twelve months. Doctors suggest either observation or 
pars plana vitrectomy (PPV) membrane peeling with intraocular gas or silicone gel 
tamponade. Gas requires facedown positioning for forty-five minutes every hour. 
For those patients who are unable or unwilling to position, silicone oil is used. In 
1999, physicians began peeling the internal limiting membrane (discussed in 
literature review). The effectiveness of the ILM peel is currently under review. The 
aim of this study is to compare treatment results between vitrectomy with or without 
ILM peeling. 
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Why is it important?  
In large part, the challenge in establishing a consensus on macular hole 
surgery is due to the very rare prevalence of macular holes; 0.03% of the 
population over age 55 (Freeman W. R., 1993). This thesis will provide context for 
the progression of macular hole, the current prophylactic and therapeutic 
treatments and an assessment of the current state of macular hole surgery. The 
specific aims of the present work are to report (1) the populations at risk for macular 
hole, (2) the effectiveness of current interventions, (3) the limitations of recent 
studies, and (4) lastly an assessment of options for the treatment of idiopathic 
macular hole. The scope of the analysis will focus most specifically on the efficacy 
of pars plana vitrectomy procedures with or without internal limiting membrane 
peeling. For this, a single-surgeon, case-control study was conducted at the Beth 
Israel Deaconess Medical Center.  
What is the problem or question? 
Despite the impressive advancements in medical care for this previously 
untreatable condition, physicians do not have access to enough evidence-based 
information. Specifically, the literature on idiopathic macular holes is vulnerable to 
control selection bias, recall bias, ascertainment bias, and inaccuracy of 
retrospective data. Macular hole is a rare condition. The unpredictability associated 
with macular holes presents practical challenges for conducting a randomized 
clinical trial. On one hand, a randomized clinical trial is the most rigorous, effective 
tool to investigating the benefit of intervention. On the other hand, a case-control 
  
14 
study is relatively straightforward and cost-effective. The case-control design also 
offers unique advantages for understanding very rare conditions. (Gordis, 2009) In 
this study, a before-after design was implemented to leverage a data set that 
includes historical controls before the implementation of a novel technique. The 
outcomes data linked to each patient in the electronic medical records were 
analyzed to answer the question: In patients with an idiopathic macular hole, which 
clinical features or test results predict the development of persistent macular 
holes? 
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 LITERATURE REVIEW 
When did the procedure first begin? 
In 1991, Neil Kelly, MD, and Robert Wendel, MD, conducting the first pilot 
study of pars plana vitrectomy (PPV) for patients with macular hole. Dr. Kelly and 
Dr. Wendel, who are both ophthalmologists, pioneered the development of 
macular hole surgery. Kelly and Wendel (1991) described their understanding of 
macular holes:  
Traditionally, macular holes have been considered untreatable … We have 
postulated that modern vitrectomy techniques could be used to improve the 
vision in eyes with macular holes. We wanted to evaluate two questions: (1) 
Is it possible to reattach the retina around the macular hole? (2) If the retina 
is reattached, will the patient’s central vision improve? (p. 654)  
The pilot study by Kelly and Wendel represents a prospective observational trial to 
assess the effectiveness of pars plana vitrectomy, which is a treatment for 
complications of proliferative diabetic retinopathy, to establish a novel treatment 
for an idiopathic macular hole. The study selected 52 patients from their practice 
who had a macular hole in at least one eye, central visual acuity of 20/50 or worse 
and stage III or IV macular holes.  The surgical procedure consisted of a pars plana 
vitrectomy, removal of adherent cortical vitreous, stripping of epiretinal 
membranes, and a total gas-fluid exchange. Successful anatomical outcome, the 
main outcome in question, was defined as macular hole closed determined by 
post-operative examination. The secondary outcome, visual acuity, was measured 
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pre-operatively and post-operatively by an independent observer using a standard 
Snellen visual acuity chart. There was no comparison group included in this pilot 
study; each patient received the same treatment. The main study findings include 
30 of 52 (58%) successful reattachment of the detached macula, 22 of 30 (73%) 
patients with successful reattachment experienced an improvement in visual acuity 
of two lines or better, 22 of 22 (100%) patients without successful reattachment 
did not have an improvement in visual acuity. The study results show that the 
identification and treatment of macular hole with pars plana vitrectomy increased 
the visual acuity in 22 of 52 (42%) patients. As the first observational study of pars 
plana vitrectomy for the treatment of macular holes, this pilot study suggests an 
association between the intervention under question with functional and anatomic 
success. The major disappointment in the study was the failure to reattach the 
macula in about 40% of the patients. The study contributed to our understanding 
of the pathogenesis of macular holes. The removal of the traction on the retina 
from the vitreous and epiretinal membranes appeared to allow reattachment of the 
retina. This finding support’s Gass’s assertion that traction may represent one of 
the major causes of idiopathic macular holes.  Furthermore, considering 73% of 
patients with successful reattachment experienced an increase in visual acuity, it 
appears that retinal tissue and photoreceptor function may not be permanently 
compromised.  
According to Kelly and Wendel, neither the hole or visual acuity will improve 
without intervention. The authors note, “Vitreoretinal surgeons do not have 
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substantial, dependable information on the treatment of idiopathic macular holes.” 
(Kelly & Wendel, 1991) This apt statement over twenty years ago is still relevant 
today. Despite major advancements in medical treatment for macular holes, the 
information on specific procedures used and best practices for physicians to 
implement in future care is limited by a number of factors. The implementation of 
pars plana vitrectomy procedures is associated with Gass’s theory that traction on 
the retina from the vitreous and Epiretinal membranes may represent one of the 
major causes of the disorder.  
The novel intervention for idiopathic macular hole suggests that vitreoretinal 
traction plays a significant role in the progression of macular holes. The pars plana 
vitrectomy alleviates vitreoretinal traction in the eye (Ryan S. J., 2001). The 
procedure, however, did not catch on quickly due to challenges associated with 
the difficulty of the procedure itself as well as a functional success rate of 42%.  
Other ophthalmologists recognized the potential in pars plana vitrectomy for 
treating macular holes and began randomized clinical trials to validate and 
standardize macular hole surgery.  
Between 1991 and 1995, surgeons experimented with vitreous surgery, 
observing whether prophylactic treatment at an early stage of macular hole 
formation would lead to more reliable outcomes. Two notable studies conducted 
by Dr. Freeman, Dr. Kim and Dr. El-Haig (Department of Ophthalmology, Shiley 
Eye Center, University of California, San Diego) showed that macular hole surgery 
was effective for stages II, III, and IV (Kim, 1996; Freeman W. R.-H., 1997). The 
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study Prospective randomized trial of vitrectomy or observation for stage 2 macular 
holes conducted by Kim et al. represents a multi-centered, controlled, randomized 
clinical trial. In this experimental trial, 36 eyes with stage II macular holes and 12 
months of follow-up were selected from 16 community- and university-based 
ophthalmology clinics. The patients were randomly assigned to an observation 
only group (n=21 eyes) or to a surgery group (n=15 eyes). The standardized 
surgical procedure consisted of pars plana vitrectomy with separation of the 
posterior hyaloid membrane and intraocular injection of perfluoropropane (C3F8) 
followed by postoperative face-down positioning for two weeks. The main 
dependent variables included anatomic closure of the macular hole, macular hole 
size and standardized measures of vision.  In this experiment, the primary outcome 
variable was incidence of hole enlargement to either stage 3 or stage 4. The major 
study findings report 15 of 21 (71%) eyes in the observation group progressed to 
stage 3 or stage 4 macular hole, compared to 3 of 15 (20%) eyes randomly 
assigned to surgery (P<0.006). The findings in the randomized control trial by Kim 
et al. support the notion that early stage macular holes will progress to full-
thickness macular holes without intervention.  
Following the study on stage 2 macular holes, Freeman et al. published a 
report titled Vitrectomy for the Treatment of Full-Thickness Stage 3 or 4 Macular 
Holes. This study represents a multi-centered, controlled, randomized clinical trial 
to examine the outcomes of standardized macular hole surgery in comparison to 
observation alone. The study included 129 eyes of patients who had a macular 
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hole classified as stage 3 or 4, clear ocular media, a pupil at least 5 mm in 
diameter, no co-existing retinal disease that could affect the functional status of 
the macula, visual acuity worse than 20/50, symptoms of decreasing central vision, 
loss of foveal tissue greater than 400 µm (micrometers) in diameter with a cuff of 
subretinal fluid, no evidence of aphakic or pseudophakic cystoid macular edema, 
and a positive Watzke - Allen test result (i.e. a break seen through a slit-beam 
projected onto the fovea). The key independent variable was surgery or 
observation. The surgical technique included 3-port pars plana vitrectomy and 
complete removal of the vitreous. Membranes were removed if encountered by 
blunt or sharp dissection. Air-fluid exchange was performed to flatten the macular 
hole. In all cases, C3F8 gas was used as the intraocular tamponade. All patients 
were instructed to face-down position for two weeks after surgery. The primary end 
point was a change in visual acuity of 2 or more lines. The major study findings 
claim a significant benefit of surgery on the rate of hole closure (4% vs 69%: 
P<.001).  
When did the procedure change?    
In 1995, Gass’s continued observation of macular hole development led him 
to update the biomicroscopic classifications of stages of development of a macular 
hole (Gass, Reappraisal of biomicrosopic classifications of stages of development 
of a macular hole, 1995). The new anatomic explanations for these stages added 
to the discourse on potential causes of macular hole. In the conclusion, Gass 
(1995) writes, “The change from a yellow spot (stage 1-A) to a yellow ring (stage 
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1-B) is caused primarily by centrifugal displacement of retinal receptors after a 
dehiscence at the umbo” (p. 752). The astute observations by Dr. Gass on the 
early stages in macular hole development are critical to the current understanding 
of the disease. Dr. Gass hypothesized that spontaneous tangential contraction of 
the prefoveolar cortical vitreous detaches the central fovea and is an important 
process in the pathogenesis of macular hole formation.  
Following Dr. Gass’s hypothesis, Yooh et al. (1996) documented cellular 
proliferation of the internal-limiting membrane. Yooh et al.  hypothesized that these 
proliferative cells undergo myofibroblastic differentiation that causes the full-
thickness macular hole to widen. The findings of this study led other investigators 
to peel the internal limiting membrane during macular hole surgery.  
The success of peeling the internal limiting membrane to improve outcomes 
in the treatment of Macular Hole was first reported in 1999. Park et al published a 
study titled “Macular Hole Surgery with Internal-limiting Membrane Peeling and 
Intravitreous air” in Ophthalmology.  In the study, all surgeries were conducted by 
a single surgeon between 1991 and 1997. The retrospective, interventional, non-
comparative case series by Park et al. (1999)  examines the association between 
pars plana vitrectomy with internal-limiting membrane peeling and macular hole 
outcome status. The study includes 64 eyes (55 consecutive patients) with full-
thickness macular holes who were referred to a single surgeon (Dr. Jack O. 
Sipperly, MD) between October 1991 and July 1997. Eyes with traumatic macular 
holes or less than 6 months’ post-surgical follow-up were excluded from the final 
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analysis. The intervention consisted of pars plana vitrectomy with posterior hyaloid 
removal. The authors note: 
 If a macular epiretinal membrane was present, it was peeled during the 
surgery. However, in all cases, a membrane (presumably the internal-
limiting membrane) [sic] was peeled from the macula using a 20-gauge 
microvitreoretinal blade, Sinskey hook, and intraocular forceps. (p. 1393) 
Despite the uncertainty on precisely which membrane was peeled, the authors 
state that 58 eyes of 50 consecutive patients underwent a PPV with internal-
limiting membrane peeling and intravitreous air. The main study findings state that 
patients receiving PPV with ILM peeling had a 91% (53 of 58 eyes) success rate 
with one operation. Furthermore, the study asserts that 95% (55 of 58 eyes) of 
macular holes closed with subsequent surgery (Park, 1999). Additionally, the study 
reports that membrane peeling may reduce the need for face-down positioning. 
In 2000, Logan Brooks, MD, conducted a retrospective, nonrandomized, 
comparative trial with concurrent control group comparing macular hole surgery 
with and without internal limiting membrane peeling. Brook’s study was the first 
large case series measuring the effect of peeling the internal limiting membrane.  
A total of 231 eyes (217 patients) were identified. Six patients with either 
insufficient follow-up or history of macular hole surgery were excluded. The 
remaining 225 eyes (211 patients) were stratified into three groups to compare ILM 
peeling or no peeling and duration of hole. All of the patients included in the study 
received care from one physician (Dr. Brooks) in Tallahassee, Florida between 
  
22 
October 1992 and October 1997. The major study findings include the success 
rate for primary hole closure of 116 of 116 (100%) and significantly better vision 
measured in the group with ILM peeling compared to the group without peeling 
(P<0.00001) (Brooks, 2000). Relevant conclusions from the study suggest that 
myofibroblastic differentiation leads to more contractile cells which may cause 
separation at the basement membrane. The author of the study reports findings of 
a previous study, “Ultrastructural features of tissue removed during macular hole 
surgery showed cells with myofibroblastic differentiation on the ILM.” (Yooh, 
Brooks, Capone, L'Hernault, & Grossniklaus, 1996) The findings in the studies 
conducted by Brooks et al. establishes the practice of performing ILM peeling in 
all macular holes greater than 300 µm. However, the impressive results reported 
in Brook’s study have not been repeated in a randomized clinical trial. (Lois, et al., 
2011)  
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METHODOLOGY 
Method of Literature Review 
The literature on macular hole surgery was searched from November 2015 
– March 2016. All studies included for the purpose of establishing a baseline 
success rate were published between 1984 and 2015 (Figure 6). A total of 2,182 
studies were identified as potential studies on ILM peeling. The abstract and title 
were screened to identify studies published in English, available for reference and 
quality of study design. Forty studies were fully reviewed to evaluate the 
progression of macular hole surgery over the past twenty-five years. Further in-
depth review of these forty studies was fundamental to understanding the 
heterogeneous results on the success of macular hole surgery.   
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Figure 6. Summary of literature search. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Records identified through database 
searching: n = 2,182 
(PubMed, Google Scholar, Cochrane 
library)   
Unrelated, overlapping and non 
English records were removed by 
browsing the titles: n = 1,350   
Abstracts screened: n = 832 
Studies included for analysis: 
n = 19 
Full-text articles assessed for 
eligibility: n = 46 
Records 
excluded:  
n = 746  
Full-text articles 
excluded: n = 27 
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Study Design 
Previous studies on macular hole surgery are predominately retrospective. 
The reason for the majority of authors selecting a retrospective design is primarily 
due to the rare occurrence of macular hole surgery. Random sampling is the 
preferred method when researchers have access to multiple sites or plan to study 
a common disorder or medical procedure. However, in cases where information is 
limited, a convenience sample is more practical. (Vassar & Holzmann, 2013) 
Considering the relatively low frequency of idiopathic macular hole, a retrospective 
study done with a high number of full-thickness macular holes not only contributes 
to the discourse on macular hole treatment, but is necessary for the development 
of future randomized clinical trials.  
This retrospective consecutive nonrandomized comparative interventional 
trial is designed to assess whether or not patients benefit from the revised pars 
plana vitrectomy procedure, which includes ILM peeling (Figure 7). The primary 
endpoint is the number (or proportion) of macular hole closure followed by surgical 
intervention. The number (or proportion) of patients readmitted for subsequent 
surgery was examined to assess the dynamics of failed operations. The secondary 
outcome is of particular interest considering the lack of information on reoperations 
in the literature. The primary outcome, whether or not internal limiting membrane 
peeling improves the likelihood of macular hole closure, was analyzed to evaluate 
the efficacy of macular hole surgery. 
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A convenience sample, in which researchers utilize medical information at 
their disposal, was the most pragmatic approach for this investigation. Two groups 
of patients were identified for comparison. One group of individuals with macular 
hole had received vitrectomy with ILM peeling. The second group of subjects with 
macular hole had received vitrectomy without ILM peeling.  The incidence of 
persistent and reopened macular hole was measured to determine the effect of 
internal limiting membrane peeling on macular hole surgery. If an inverse 
association exists between the intervention and outcome, we would expect the 
proportion of the treated group in whom the disease develops would be less than 
the proportion (incidence) in the non-treated group.    
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ILM, internal limiting membrane.  
 
 
 
 
 
  
Figure 7. Study design. 
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Null Hypothesis Tested 
There is no significant difference in the average success (macular hole 
closure) rate between groups with or without internal limiting membrane peeling.  
Subjects and Screening 
This retrospective study examined subjects who were treated by a single-
surgeon (Dr. Arroyo). A total of 1,377 individuals accessed through a single clinic 
in Boston, Massachusetts were considered for participation: 2,023 surgical 
procedure records were screened to identify 130 patients with a macular hole. The 
study included both men and women who were over 18 years old, diagnosed with 
macular hole and received care from Dr. Jorge Arroyo, M.D., M.P.H, at the Beth 
Israel Deaconess Medical Center. At the time of enrollment, subjects were not 
required to take any additional action. All of the information necessary for the 
purpose of this medical record review was available at the time of investigation: 
outcome and demographic information was abstracted from clinic medical records. 
107 cases (72 individuals) were excluded due to concurrent eye disease in either 
eye or limited follow-up.   
The medical records were screened between December 11, 2015 and 
March 1, 2016 by a single reviewer. Although the database was maintained 
primarily for billing purposes, the primary investigator had intentions to use the 
data set for medical outcomes research. The dataset included 69 surgical 
procedures conducted between December 1999 and January 2015. The unique 
medical record number (MRN) was used to determine a total of 58 individual 
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patients.  In an initial assessment of the data, 81 unique labels for pre-surgery 
diagnosis were associated with macular holes. Reasons for the various labels 
included comorbidities such as cataracts, proliferative diabetic retinopathy, 
epiretinal membrane and retinal detachment. The diagnosis labels were revised to 
accurately reflect the status of the macular hole (Full-thickness macular hole, 
reopened macular hole, or persistent macular hole). Additionally, all comorbidities 
and eye (right or left) were preserved in the revised spreadsheet. 
The revised spreadsheet was used to determine eligibility for inclusion in 
the study. Patients with Stage 2, 3, or 4 macular holes were considered for 
eligibility. Patients with history of retinal detachment, trauma, peripheral diabetic 
retinopathy, cerebrovascular disease, asteroid hyalosis, pterygium, age-related 
macular degeneration, lattice degeneration, drusen, posterior vitreous detachment 
or ocriplasmin injection were classified as non-idiopathic macular hole.  Six 
individuals (n= 14 procedures) with aforementioned history of ocular disease were 
excluded.  In total, 55 eyes of 52 patients were eligible for inclusion in the study.  
Surgical Intervention 
 The primary surgical intervention was pars plana vitrectomy. Arroyo 
(2016) describes the components of the surgery: 
 With this procedure, (1) three sclerotomies are made on the outside of the 
eye, one that allows fluid to infuse into the eye, and two others that are used 
to introduce instruments into the back part of the eye. (2) Using a light pipe 
and a vitreous cutter, the surgeon creates a posterior vitreous separation. 
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(3) Epiretinal membranes are removed if present. (4) ILM peeling and (5) 
intraocular tamponade. (J. Arroyo, personal communication, March 19, 
2016). 
In this comparative series, the surgical procedure was performed by Dr. Jorge 
Arroyo on an outpatient basis. The indication, risks, benefits and alternatives were 
discussed with the patients in the process of obtaining informed consent. For each 
patient, EKG, O2, and blood pressure monitors were placed and monitored in the 
operating room. All procedures were performed with monitored anesthesia care 
with peribulbar infusion. A retrobulbar infusion of a 50:50 mixture of 2% lidocaine 
and 0.75% Marcaine with epinephrine was given behind the operative eye to 
produce suitable anesthesia and akinesia.  
The surgical procedure consisted of a pars plana vitrectomy, removal of 
adherent cortical vitreous, stripping of membranes, and a total fluid exchange.  The 
light pipe and vitreous cutter were used to perform a complete central and 
peripheral vitrectomy. At the time, the surgeon inspected each eye for a posterior 
vitreous detachment. The vitreous cutter was used on aspiration to peel the 
posterior hyaloid off of the optic nerve out to the periphery.  
For the specific intervention, indocyanine green (ICG) dye was injected to 
stain the internal-limiting membrane (ILM) for 31 (75%) of 39 eyes in the ILM 
peeling group. ILM forceps were used to grasp the edge of the internal-limiting 
membrane and to peel it completely around the macular hole and out to the 
temporal arcades. A careful 360-degree scleral depression examination was 
  
31 
performed twice to identify potential retinal tears or retinal detachments.  If one 
was found, laser or cyroretinopexy was applied around the break.   A fluid-
exchange with either silicone oil (n=13), SF6 gas (n=32) or C3F8 gas (n =10) was 
performed. Then the sclerotomies were closed and examined to confirm water-
tight closure. Pressures of each eye were checked at the conclusion of the case.  
A sub-conjunctival injection of Kefzol and Dexamethasone was given. The 
operative eye was patched with 1 drop of scopolamine 0.25%, Bacitracin ointment, 
a soft eye pad and a hard eye shield.  
Follow-up Visits 
Patients were scheduled for post-operative follow-up visit between 1 day 
and 7 days after the pars plana vitrectomy with or without internal limiting 
membrane peeling. All patients included in this study were seen for at one follow-
up visit with an average of 34.2 months of follow-up. Visual assessments for best-
corrected visual acuity (BCVA) were performed by a technician at each visit. Dr. 
Arroyo used indirect ophthalmoscopy to determine that status of macular hole. 
Optical Coherence Tomography (OCT) imaging of the retina was used to 
document the findings.  
Assessment of Outcomes 
The main independent variables in this study were internal limiting 
membrane peeling qualitatively measured by either peeling, partial peeling or no 
peeling. The main dependent variables under study were the occurrence of failed 
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treatment as defined by macular hole status as unclosed and visual acuity 
measured by a standard Snellen chart. Conversion of Snellen acuity to logarithm 
of the minimum angle of resolution (logMAR) values for purposes of statistical 
analysis was performed. According to the standard equation, visual acuity of 20/20 
corresponds to a minimum angle of resolution of 1.0 and a visual acuity of 20/200 
corresponds to a 10.0 minimum angle of resolution. The natural logarithm of the 
minimum angle of resolution provides the values 0 and 1 for 20/20 and 20/200, 
respectively.     
A chart review was performed by the author on 55 eyes of 52 individuals 
who had macular hole surgery between December 1999 and January 2015. 
Macular hole diagnosis was abstracted using operative notes and confirmed with 
Ocular Coherence Tomographic (OCT) imaging. A macular OCT image was 
obtained pre-operatively and post-operatively using the Zeiss Stratus OCT unit 
(Carl Zeiss Meditech, Dublin, California, USA). When OCT imaging was not 
available, patient report letters addressed to the primary care physician were used 
to confirm status of macular hole condition. Pre-operative and post-operative visual 
acuity measurements were abstracted from clinical reports.  
Sample Size and Statistical Analysis  
G*Power 3.1 was used to determine the parameters of statistical tests. For 
the primary outcome, data from the most recently conducted randomized control 
were used to establish proportion p1 of 0.84 and a proportion p2 of 0.48 (Lois, et 
al., 2011). The alpha level of statistical significance was set to 0.05 and the power 
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(1 – β) was set to 0.8. The allocation ration N2/N1 was 1. The output parameters 
of an A priori power analysis, provided by G*Power 3.1, included sample size 
group 1 (n=25), sample size group 2 (n = 25), a total sample size (N=50), actual 
power was 0.8048 and actual α was 0.0323 (Paul, Erdfelder, Lang, & Buchner, 
2007).  
Comparison of continuous variables was performed with 2-tailed paired t-
test and 2 tailed independent t tests. Analysis of the categorical variables was 
conducted via the Fisher’s exact test. The success rate for primary surgery was 
calculated using proportions of people with open macular holes compared to 
patients with closed macular holes. A mean difference of change in Snellen lines 
(logMAR) was reported for independent groups. Patient-matched BCVA in each 
group was compared using the paired t-test. The principal analysis was based on 
available case data with no imputation of missing values.  
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DATA 
Patients 
Over a seventeen-year period, a total of 55 eyes of 52 individuals with 
idiopathic age-related macular hole were included in the retrospective chart review 
for this study (Table 1 and Table 2). A total of 50 out of 55 (91%) cases presented 
with a full-thickness macular hole without posterior vitreous detachment. The 
remaining 5 out of 55 (9%) cases presented with a stage 4 macular hole (Table 1). 
Surgical outcome data was available for all patients included in the study; however, 
information on visual acuity data was available for 28 out of 55 (50.1%) eyes. 
Demographic Data 
The mean age was 66.7 years, ranging from 47 - 86 years. There were 46 
(88%) females and 6 (12%) males. The age distribution was similar between 
groups with and without ILM peeling (Table 1).  The female: male ratio was 7:1 in 
the group without ILM peeling versus 6.8:1 in the group that received ILM peeling. 
The predominance of women included in this study is consistent with the etiology 
of idiopathic macular holes (Vaughan, 1992). 
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ILM, internal limiting membrane.  
 
 
 
 
 
 
 
  
Average of Age_Case ILM Peeling No Peeling
Number of eyes (n) 39 16
Gender (Female:Male) 34:5 14:2
Mean age (years) 67.75 64.13
(range, 52 - 86) (range, 47 - 84)
Stage 2 macular holes 4 7
Stage 3 macular holes 30 9
Stage 4 macular holes 5 0
Table 1. Demographic summary.  
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Case Number Gender Age (years) Eye Macular Hole Status
Preoperative VA 
(Snellen)
Postoperative VA
(Snellen)
1 F 65 OS Stage 3 20/100 /
2 F 47 OD Stage 3 20/100 20/50
3 F 52 OD Stage 3 / /
4 F 51 OD Stage 2 20/400 20/30
5 F 69 OS Stage 2 / 20/30
6 F 79 OS Stage 4 20/400 20/200
7 F 55 OD Stage 2 20/70 20/40
8 M 78 OS Stage 3 20/200 /
9 F 70 OD Stage 3 20/60 20/30
10 F 53 OD Stage 2 20/200 20/30
11 F 67 OS Stage 2 20/100 /
12 F 73 OD Stage 3 / 20/60
13 M 55 OS Stage 3 / /
14 F 84 OS Stage 3 20/400 20/200
15 F 67 OD Stage 3 20/200 /
16 F 61 OD Stage 3 20/200 20/50
17 F 65 OD Stage 3 / 20/200
18 F 64 OD Stage 3 / /
19 F 61 OS Stage 3 20/60 20/860
20 F 66 OD Stage 2 20/860 20/200
21 F 65 OS Stage 2 20/400 20/25
22 F 58 OD Stage 4 20/400 20/60
23 F 65 OS Stage 3 20/80 20/860
24 F 62 OD Stage 2 20/200 20/50
25 F 69 OS Stage 4 20/60 20/30
26 F 70 OD Stage 3 20/200 20/30
27 F 62 OD Stage 2 20/200 20/30
28 F 62 OD Stage 3 20/400 20/40
29 F 69 OD Stage 3 20/400 20/60
30 F 65 OD Stage 3 20/80 20/200
31 F 69 OD Stage 3 20/100 20/25
32 F 64 OS Stage 2 / /
33 F 60 OS Stage 3 20/400 20/200
34 M 74 OD Stage 4 20/100 20/20
35 F 79 OD Stage 3 / 20/25
36 F 60 OS Stage 3 / 20/100
37 F 75 OD Stage 3 20/80 20/150
38 M 69 OD Stage 3 / 20/30
39 F 86 OD Stage 3 20/400 20/40
40 F 72 OS Stage 3 / /
41 F 68 OS Stage 3 20/400 20/40
42 M 79 OS Stage 3 / 20/30
43 M 81 OD Stage 3 / 20/60
44 F 56 OS Stage 3 20/80 20/25
45 F 74 OS Stage 3 20/200 20/200
46 F 72 OD Stage 3 20/860 20/400
47 F 57 OD Stage 2 20/200 20/20
48 F 70 OS Stage 3 / /
49 F 60 OS Stage 3 20/200 20/30
50 F 67 OD Stage 4 20/60 20/40
51 F 63 OD Stage 3 20/40 /
52 F 73 OD Stage 3 20/100 20/30
53 F 68 OD Stage 3 20/200 20/860
54 F 65 OS Stage 3 20/100 20/60
55 M 78 OS Stage 3 20/200 20/80
Table 2. Case characteristics. 
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Primary endpoint: macular hole surgery outcome 
The main dependent variable in this study was closure of macular hole 
following vitrectomy (Figure 8). 47 of 55 (85.5%) of cases were determined to be 
successful, as indicated by macular hole closure observed in clinical examination 
or ocular coherence tomography. The primary independent variable under study 
was vitrectomy with or without ILM peeling (Table 3). All vitrectomy cases without 
peeling were conducted between December 1999 and February 2008. The first 
revised procedure including ILM peeling took place in October 2003. Beginning in 
August 2008, Dr. Arroyo peels the ILM in 34 of 34 (100%) of the procedures up 
until January 2015. 
The full-thickness macular hole was closed (Figure 10) with one surgery for 
the entire duration of follow-up in 36 of 39 (92.3%) eyes in the ILM peeling group 
compared with 11 of 16 (68.8%) eyes without ILM peeling (P = 0.038). Eight eyes 
developed either a persistent or a reopened macular hole (14.5%). Macular holes 
status was considered unclosed if the macular hole did not close or closed and 
then reopened. In the ILM Peeling group, 2 (5.5%) eyes developed a persistent 
FTMH and 1 (2.7%) developed a recurrent FTMH. In the no peeling group, 2 
(12.5%) developed a persistent macular hole and 3 (18.8%) developed a recurrent 
macular hole. These eyes either received additional treatment or were determined 
to be chronic macular holes that would not benefit from further treatment. Figure 9 
shows the breakdown of macular hole surgery outcome separated by group.   
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OCT, Optical coherence tomography 
 
 
 
 
  
Figure 8. OCT of retina comparing (A) preoperative idiopathic full-thickness 
macular hole versus (B) post-operative closed retina. 
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ILM, internal limiting membrane. 
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Grand	Total Closed Unclosed
ILM Peeling 36 3
No Peeling 11 5
Table 3. Major outcome of macular hole surgery grouped by ILM peeling or 
no peeling. 
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Visual acuity results after macular hole surgery 
Visual acuity was compared within groups to assess improvement of 
patients after the procedure. 28 of 55 eyes had follow-up data for best corrected 
visual acuity (BCVA). 17 out of 20 (85%) eyes with ILM peel had improved vision 
of three lines or better at last follow-up visit. 1 out of 20 (5%) eyes gained 2 lines 
improvement in visual acuity. 2 out of 20 (10%) eyes had a decrease in vision. The 
average change in vision for all patients in the ILM peeling group was mean 0.55 
[95% CI: 0.37 to 0.72]. The average change in vision for patients in the no peeling 
group was mean 0.61 [95%CI: 0.33 to 0.88].  
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Figure 12. Histogram of VA comparing before and after ILM peeling. 
ILM, internal limiting membrane; VA, visual acuity.  
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The scatter plot shows paired values of BCVA before and after PPV separated 
by ILM or no ILM group. The line in the middle of the graph separates patients 
whose vision improved from those patients whose vision decreased. Values 
below the line finish with smaller BCVA values (improvement in vision). 
 
ILM, internal limiting membrane; BCVA, best-corrected visual acuity; logMAR, 
logarithm of the minimum angle of resolution. 
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A comparison between average change in vision in ILM peeling (mean = 0.55) 
and no peeling (mean = 0.61) showed non-significant difference (P = 0.3418).  
Figure 13 displays a scatterplot of matched values for patient’s pre-operation and 
post-operation visual acuity. The line in the middle separates the patients whose 
vision improved from the patients whose vision worsened. Values under the line 
represent patients who had lower logMAR values after the procedure (indicating 
functional success).  
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DISCUSSION AND RECOMMENDATIONS 
Discussion 
This study of 55 macular hole surgeries showed a significantly higher 
anatomic success rate of macular hole closure after ILM peeling than in macular 
hole surgery without ILM peeling. The functional success measurements of visual 
acuity suggest that both PPV with or without ILM peeling are associated with an 
increase in visual acuity.  
Pathophysiological mechanism 
According to Adler’s Physiology of the Eye, “It is likely that macular holes 
represent the end stage manifestation of more than one pathophysiologic 
sequence.” (Hart, 1992)  The role of peeling the ILM is associated with relieving 
residual tangential traction on the fovea that may remain after posterior hyaloid. 
Considering the success of peeling the internal limiting membrane in macular hole 
surgery, tangential traction is likely a major factor in the development of macular 
holes.   
Limitations 
Due to the nonstandardized examinations as technology and staff changed 
over the seventeen-year period covered in this chart review, visual acuity data is 
not necessarily recorded with enough consistency to make statistically significant 
inferences.  However, the positive trend of improvement in vision observed 
between pre- and post-operation visits for both groups is consistent with the 
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literature on pars plana vitrectomy for macular hole surgery. Furthermore, while 
studies have suggested that ILM peeling may negatively affect visual acuity 
outcomes, a recent meta-analysis claims no significant difference were observed 
(Rahimy & McCannel, 2015). Furthermore, a randomized controlled trial 
conducted by Lois et al. supports the notion that there is sufficient evidence to rule 
out a previously suggested benefit in visual acuity for those patients without ILM 
peeling. (Lois, et al., 2011). A multi-centered, prospective, randomized, controlled 
study would be needed to validate these findings and better quantify the benefits 
and risks of ILM peeling during macular hole surgery. 
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APPENDIX 
 
 
 
Table 4. Visual acuity. 
 
 
 
  
Visual acuity values converted into decimal and logMAR notation.
Snellen Decimal logMAR
20/860 0.02 1.6
20/640 0.03 1.5
20/500 0.04 1.4
20/400 0.05 1.3
20/320 0.063 1.2
20/250 0.08 1.1
20/200 0.10 1
20/160 0.125 0.9
20/125 0.16 0.8
20/100 0.20 0.7
20/80 0.25 0.6
20/63 0.32 0.5
20/50 0.40 0.4
20/40 0.50 0.3
20/32 0.63 0.2
20/25 0.80 0.1
20/20 1.00 0
20/16 1.25 -0.1
20/12.5 1.60 -0.2
20/10 2.00 -0.3
logMAR, logarithm of the minimum angle of resolution.
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Coral Gables, FL 33134       Brookline, MA 02446 
______________________________________________________________________________________ 
Narrative Summary 
During my involvement with Unite For Sight (UFS), I developed a strong reputation 
as a leader committed to improving global eye care, engaged in community service in my 
specific clinical interest, age-related blindness, and demonstrated a record of excellence 
and commitment to patient education and community service.  
In the Medical Science Masters Program at Boston University, I strengthened my 
foundation in the biomedical sciences. As a graduate student, I gained experiences in data 
analysis of surgical outcomes, evidence-based medicine and patient-centered care.  At 
the BIDMC, I use the slit lamp and indirect ophthalmoscope to examine and better 
understand the pathophysiology of common vitreoretinal diseases.  
Finally, I am a highly motivated and goal-oriented individual with plans to make a 
difference in the field of medicine.  I am passionate about helping others and pursuing 
leadership roles in the community.  My passion for science and diverse experiences in 
clinical internships, global health projects and advocacy campaigns form the basis for my 
decision to pursue a career dedicated to patient care, education, research and community 
service.  
______________________________________________________________________________________ 
Education 
M.S. in Medical Science, Boston University, Boston, MA 2013 – 2016 
B.A. in Public Health, Johns Hopkins University, Baltimore, MA 2009 – 2013 
______________________________________________________________________________________ 
Leadership and Community Service 
Volunteer  July 2015 – May 2016 
Cambridge Health Alliance, Cambridge, MA  
• Directly contributed to the medical care of an underserved population. 
Volunteer March 2015 – October 2015 
Greater Boston Food Bank, Boston, MA  
• Organized grocery products for distribution to hunger relief agencies.  
Founder, President and Chair July 2010 –  May 2013 
Unite For Sight Community Charter  
Johns Hopkins University, Baltimore, MD      
• Organized bi-monthly events to support self-sustainable eye clinics in Ghana. 
• Presented material to elementary schools about identifying visual issues and 
coordinating care.  
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______________________________________________________________________________________ 
Clinical Experience 
Clinical Research Student Intern  2015 – 2016 
• Acting as a physician’s scribe during rounds and laser procedures. 
• Assisting in clinical activities such as pre- and post- intravitreal injection. 
• Obtaining patient history and performing visual assessments. 
Shadowing 2010 – 2016 
• Accompanied vascular surgeon, obstetrician, and dermatologist on rounds. 
• Observed cataract and refractive surgeries, including PRK and all laser LASIK. 
Global Impact Fellow (two trips)  July 2010 and January 2011 
Dr. James Clark, MD, Ophthalmologist,  
Accra, Ghana  
• Trekked 3-8 hours via van for outreach visits to remote, rural villages. 
• Supported and assisted the local eye clinic staff by taking patient history, testing 
visual acuity, distributing the glasses and medication prescribed by the local eye 
doctors, helping to coordinate surgery by the local ophthalmologists, and 
administering health education materials. 
• Fundraised over $7,500 to sponsor 150 sight-restoring operations. 
• Awarded Unite For Sight Volunteer of the Year, 2010. 
______________________________________________________________________________________ 
Research Experience 
Clinical Research Student Intern  July 2015 – May 2016 
PI: Jorge Arroyo, M.D., M.P.H. 
Division of Ophthalmology 
Beth Israel Deaconess Medical Center 
Harvard Medical School 
I investigated the efficacy and outcome of internal limiting membrane (ILM) peels 
in the treatment of idiopathic macular holes. Using optical coherence tomography (OCT), 
I examined the structure of the retina before and after macular hole surgery.  I established 
a database of surgical records and used statistical analysis to quantify the success of ILM 
peeling.  
• Brainstorming and designing an independent research project. 
• Abstracting patient information from medical records.  
• Analyzing outcomes-based information of surgical history.  
 
Research Assistant January 2012 – May 2013 
Dept. of Psychological and Brain Science 
Johns Hopkins University  
PI: Michael Yassa, Ph.D. 
I used neuroimaging tools such as high-resolution functional MRI and ultrahigh-
resolution (sub-millimeter) diffusion imaging to examine the mechanisms that underlie 
long-term memory function in vivo. 
• Developed digital database for confidential information collection system. 
• Analyzed data using Excel and Matlab statistical software. 
• Conducted computer-based emotional memory tests with human subjects. 
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______________________________________________________________________________________ 
Research Skills 
Computer 
• Proficient in R, Matlab, Excel, Word, Powerpoint, and Zotero. 
Online Research Education 
• Earned certificates in the following: CITI Responsible Conduct in Research, 
Human Subjects Research & Conflict of Interest, Authorship, Data Management, 
Medical Informatics, Medical Professionalism, Evidence-Based Medicine, 
Research Misconduct, and Cultural Competency.  
______________________________________________________________________________________ 
Conference Posters: 
1. Levitt E, Yu G, Bassiri A, Arroyo JG. Ocular Coherence Tomographic Imaging in 
Patients with Recurrent Full Thickness Macular Holes. The Annual Meeting of the 
Association for Research in Vision and Ophthalmology (ARVO); 2016 May 1-6; 
Seattle, WA.  
2. Yu G, Levitt E, Bassiri A, Arroyo JG. Magnetic Resonance Angiography of the 
Choroid in Patients with Age-Related Macular Degeneration. The Annual Meeting 
of the Association for Research in Vision and Ophthalmology (ARVO); 2016 May 
1-6; Seattle, WA.  
3.  Leal, S.L., McNary, G., Levitt, E., & Yassa, M.A. (2012). A dual role for 
amygdala-mediated emotional modulation of hippocampal pattern separation. 
Society for Neuroscience. 
4. Yassa, M.A., Leal, S.L., McNary, G., & Levitt, E. (2012). Pattern separation of 
negative emotional stimuli is enhanced in depressed adults. Society for 
Neuroscience.  
______________________________________________________________________________________ 
Teaching Experience 
Teacher  Summer 2014, Summer 2015 and Spring 2016 
Examkrackers   
Harvard University and Boston University 
• Instructed students in a ten-week preparatory course for the Medical College 
Admissions Test.  
• Prepared and presented fifty-minute lecture for each subject.  
______________________________________________________________________________________ 
Hobbies          
Extracurricular Ongoing 
• Avid reader, expert snowboarder and passionate about cooking 
• Proficient in fishing and scuba. 
• Intramural basketball and soccer. 
⎯ Multiple intramural championship victories at Johns Hopkins University. 
• Finished in top 5% of all runners at the Boston Half-Marathon.        October 2015 
⎯ Time: 1 hour and 33 minutes (~7 min pace per mile)  
Avocations Ongoing 
• Advocating to eliminate preventable blindness. 
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______________________________________________________________________________________ 
Athletics 
Intercollegiate 2009 – 2012 
Johns Hopkins University Varsity Water Polo   
• Won DIII National Championship, 2009.  
• CWPA DIII Eastern Champions, 2009, 2011, 2012. 
High school 
Ransom Everglades Varsity Water Polo 
• Guided team to State of Florida Championship, 2008. 
• All-American, 2009. 
• All-Dade, 2008 and 2009. 
International 
• Member of United States Junior level pre-Olympic team.  
• Won gold medal at Maccabi Pan-American Games, 2007.  
______________________________________________________________________________________ 
Professional Societies 
Member 
Association for Research in Vision and Ophthalmology 2015 – Current 
Unite For Sight Global Health Society 2010 – Current 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
